You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

BENADRYL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Benadryl, and what generic alternatives are available?

Benadryl is a drug marketed by Mcneil Cons and is included in three NDAs.

The generic ingredient in BENADRYL is diphenhydramine hydrochloride. There are twenty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Benadryl

A generic version of BENADRYL was approved as diphenhydramine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for BENADRYL?
  • What are the global sales for BENADRYL?
  • What is Average Wholesale Price for BENADRYL?
Summary for BENADRYL
Drug patent expirations by year for BENADRYL
Drug Sales Revenue Trends for BENADRYL

See drug sales revenues for BENADRYL

Recent Clinical Trials for BENADRYL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Washington University School of MedicinePhase 2
Assertio Holdings, IncPhase 2
Dayton Children's HospitalN/A

See all BENADRYL clinical trials

US Patents and Regulatory Information for BENADRYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mcneil Cons BENADRYL diphenhydramine hydrochloride CAPSULE;ORAL 005845-007 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mcneil Cons BENADRYL diphenhydramine hydrochloride INJECTABLE;INJECTION 006146-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mcneil Cons BENADRYL diphenhydramine hydrochloride CAPSULE;ORAL 005845-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mcneil Cons BENADRYL diphenhydramine hydrochloride ELIXIR;ORAL 005845-004 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mcneil Cons BENADRYL PRESERVATIVE FREE diphenhydramine hydrochloride INJECTABLE;INJECTION 009486-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.